Project Grant HT94252510846
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $4.9M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
- This $5,620,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund MDMA-assisted massed exposure therapy for the treatment of post-traumatic stress disorder (PTSD) at Emory University in Atlanta, Georgia. The award will support advanced biomedical research to develop innovative medical solutions that address critical health challenges relevant to military personnel and civilian populations. The project has a...
- Yale University received a $1,351,106 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning July 1, 2023 will support research to identify circuit mechanisms of MDMA and methylone in order to develop plasticity-based post-traumatic stress disorder (PTSD) treatment. Through this funding, Yale researchers will investigate medical solutions applicable to battlefield conditions by...
- The Defense Health Agency awarded a $488,086 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS," is intended to support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The performance period...
- This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $307,511.00 to the University of Maryland, Baltimore (UMB) to facilitate the extinction of fear with psilocybin. The performance period runs from Feb 1, 2024 to Jan 31, 2026. The Military Medical Research and Development program supports a range of biomedical research aimed at improving the health and care of military service members, veterans, and...
- The Defense Health Agency awarded a $783,023 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "A PRECISION-MEDICINE APPROACH TO TARGETING ACQUIRED THERAPEUTIC RESISTANCE IN RTK-MUTATED NSCLC" over a 3-year period from June 1, 2025 to May 31, 2028. The Military Medical Research and Development program supports advanced...
- The U.S. Defense Health Agency awarded a $4,626,921 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period of August 1, 2025 to July 31, 2028, will fund research to elucidate the role of the neurovascular unit and related structural and functional neurological sequelae after exposure to repeated blast. This research aims to transform...
- This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
- This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
- This federal Project Grant award in the amount of $633,310.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, with a performance period from July 1, 2024 to June 30, 2027, will fund the University of Haifa in Israel to develop a novel drug to prevent PTSD or reduce symptoms in individuals already diagnosed with PTSD. The University of Haifa has a track record of conducting academic research projects across various...
- This federal Project Grant award of $6,381,198 from the Defense Health Agency was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on August 1, 2024. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research initiatives to improve health outcomes for military personnel, veterans, and the public. The "GET BETTER TOGETHER: A PRIMARY PREVENTION INTERVENTION FOR MILITARY...